Detalhe da pesquisa
1.
Return of individual genomic research results within the PRAEGNANT multicenter registry study.
Breast Cancer Res Treat
; 197(2): 355-368, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36409394
2.
Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.
Future Oncol
; 18(9): 1089-1101, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098723
3.
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting.
Int J Mol Sci
; 23(15)2022 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955851
4.
Macromastia: an economic burden? A disease cost analysis based on real-world data in Germany.
Arch Gynecol Obstet
; 303(2): 521-531, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123809
5.
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany.
BMC Cancer
; 20(1): 1091, 2020 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33176725
6.
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center.
Arch Gynecol Obstet
; 301(5): 1299-1306, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32274639
7.
[DNVF Memorandum Health Services Research in Oncology]. / DNVF-Memorandum Versorgungsforschung in der Onkologie.
Gesundheitswesen
; 82(8-09): e108-e121, 2020 Sep.
Artigo
em Alemão
| MEDLINE | ID: mdl-32858754
8.
Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial.
Int J Cancer
; 144(4): 877-885, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29992557
9.
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.
Int J Cancer
; 145(8): 2114-2121, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30901076
10.
Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 175(3): 617-625, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30868391
11.
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis.
Breast Cancer Res Treat
; 173(2): 319-328, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30324275
12.
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 174(2): 453-461, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30603996
13.
An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study.
J Med Internet Res
; 21(1): e10004, 2019 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30668517
14.
Quality of life and oncological outcome in endometrial cancer patients after vaginal brachytherapy: comparison of two dosing schemes.
Arch Gynecol Obstet
; 299(2): 507-514, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30357499
15.
Oncoplastic breast-conserving surgery: More relevant than ever? Results of a survey among breast surgeons.
Arch Gynecol Obstet
; 299(4): 1109-1114, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30656445
16.
[Resilience, Fear of Progression and Psychosocial Distress in Patients with Breast Cancer and Gynecological Tumors Seeking a Second Opinion]. / Resilienz, Progredienzangst und psychische Belastungen bei Patientinnen mit Brustkrebs und gynäkologischen Tumoren, die eine ärztliche Zweitmeinung einholen.
Psychother Psychosom Med Psychol
; 69(7): 293-300, 2019 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-30326537
17.
The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer.
Breast Cancer Res Treat
; 171(3): 747-758, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29951969
18.
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.
Breast Cancer Res Treat
; 171(1): 85-94, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29725888
19.
Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
BMC Cancer
; 18(1): 926, 2018 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30257646
20.
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer.
BMC Cancer
; 18(1): 1051, 2018 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30373556